Dual Adjuvant‐Loaded Peptide Antigen Self‐Assembly Potentiates Dendritic Cell‐Mediated Tumor Immunotherapy

Dual Adjuvant‐Loaded Peptide Antigen Self‐Assembly Potentiates Dendritic Cell‐Mediated Tumor Immunotherapy

Abstract Clinical translation of current cancer vaccine research has been hampered by limited antitumor immune responses due to inefficient antigen delivery and presentation, suboptimal DC and T cell activation. Biomaterial‐based nanovaccine offers targeted antigen delivery, protection from degradat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jaehyun Kim, Seyoung Kang, Jisu Kim, Seok‐Beom Yong, Shayan Fakhraei Lahiji, Yong‐Hee Kim
Format:	Article
Language:	English
Published:	Wiley 2024-09-01
Series:	Advanced Science
Subjects:	dendritic cell immunotherapy immune checkpoint blockade self‐assembly therapeutic cancer vaccine tumor‐associated antigen
Online Access:	https://doi.org/10.1002/advs.202403663
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade
by: Daniel A. Ruiz-Torres, et al.
Published: (2024-12-01)

Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01)

D609 Suppresses Antituberculosis Response by Regulating Dendritic Cells Antigen Presentation
by: Honglin Liu, et al.
Published: (2024-12-01)

Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy
by: Juan Yue, et al.
Published: (2022-04-01)

A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
by: Ginette S. Santiago-Sánchez, et al.
Published: (2024-12-01)

Dendritic Gold Nanoparticles Loaded on 3D Graphene-like Surface and Layer-by-Layer Assembly for Enhanced Glucose Biosensing
by: Zifeng Zhu, et al.
Published: (2025-04-01)

Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies
by: Shiding Ying, et al.
Published: (2025-05-01)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
by: Ichwaku Rastogi, et al.
Published: (2023-12-01)

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
by: Robert O Dillman, et al.
Published: (2019-06-01)

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01)

Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma
by: Athanasios Seretis, et al.
Published: (2025-03-01)

Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy
by: Rong Duan, et al.
Published: (2024-08-01)

Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC
by: Jiayi Hu, et al.
Published: (2025-05-01)

Injectable celastrol-loading emulsion hydrogel for immunotherapy of low-immunogenic cancer
by: Yu Liu, et al.
Published: (2025-03-01)

Cytoplasmic HMGB2 orchestrates CALR translocation in the course of immunogenic cell death
by: Peng Liu, et al.
Published: (2024-12-01)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
by: Naisheng Zheng, et al.
Published: (2023-12-01)

The effect of immunomodulatory celecoxsib on the gene expression of inhibitory receptors in dendritic cells generated from monocyte cells
by: Vida Hashemi, et al.
Published: (2025-04-01)

Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy
by: Ileana Soto Mauldin, et al.
Published: (2025-04-01)

Dendritic cell-based immunotherapy for head and neck squamous cell carcinoma: advances and challenges
by: Wenyue Chen, et al.
Published: (2025-05-01)

Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
by: Qiongjie Hu, et al.
Published: (2025-03-01)

New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
by: Zélia Silva, et al.
Published: (2024-11-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
by: Paul G. Pavicic, et al.
Published: (2023-12-01)

An immune activator encapsulating PD-L1 siRNA for augmented immune checkpoint blockade immunotherapy through Zn2+ overload triggered pyroptosis
by: Liming Gong, et al.
Published: (2025-06-01)

Nanoliposome-encapsulated MAGE peptides: A promising melanoma vaccine to activate human dendritic cells
by: Azin Bavafa, et al.
Published: (2025-05-01)

STUDY OF DENDRITIC CELL MIGRATION USING CELL-IQ ANALYSIS SYSTEM
by: T. L. Nekhaeva, et al.
Published: (2018-09-01)

iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
by: Bicheng Ye, et al.
Published: (2025-04-01)

Cell-autonomous reduction of CYFIP2 changes dendrite length, dendritic protrusion morphology, and inhibitory synapse density in the hippocampal CA1 pyramidal neurons of 17-month-old mice
by: Yoonhee Kim, et al.
Published: (2024-12-01)

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
by: Jenny Bulgarelli, et al.
Published: (2025-04-01)

Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
by: Quanlan Fu, et al.
Published: (2024-12-01)

IMMUNOTHERAPY FOR MELANOMA
by: E. A. Borobova, et al.
Published: (2017-09-01)

TIM-3 expression on monocyte-derived dendritic cells
by: T. V. Tyrinova, et al.
Published: (2024-09-01)

Neighboring Effect‐Initiated Supramolecular Nanocomplex with Sequential Infiltration as Irreversible Apoptosis Inducer for Synergetic Chemo‐Immunotherapy
by: Mengjie Ye, et al.
Published: (2024-10-01)

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
by: Niklas Klümper, et al.
Published: (2023-12-01)

Strategies for in situ reprogramming of tumor cells into antigen-presenting cells
by: LIN Yongfang, et al.
Published: (2024-11-01)

IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024-11-01)

Leveraging dendritic complexity for neuromorphic computing
by: Suma G Cardwell, et al.
Published: (2025-01-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01)

Development of in vitro laboratory models of the tumor immune microenvironment to evaluate quality parameters and specific efficacy of the dendritic cell vaccine
by: T. L. Nekhaeva, et al.
Published: (2023-02-01)